You are here: Home Our Members Principal Investigators
Bernd Kammerer Profile Page
Bernd Kammerer


Lab: Prof. Dr. Bernd Kammerer
Department: ZBSA - Metabolomics
Address: Habsburgerstr. 49
79104 Freiburg
Phone: +49 (0)761 203 97137
E-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it
Lab homepage:
PhD positions available: YES
Research Area: Molecular Medicine
Research Interests: • Regulation of plant biochemical pathways to investigate central metabolism, biosynthesis of secondary metabolites, signalling and stress response
• Biosynthesis and analysis of secondary metabolites from different bacterial strains as new therapeutic agents by „combinatorial biosynthesis”
• Metabolomics to unravel molecular mechanisms involved in Parkinson's disease
• Biomarker identification in breast cancer
• Metabolomics Changes in Ciliopathy: The role of the nephronophthisis Anks6 module in development and tissue homeostasis
• Analysis of the mitochondrial metabolome smORF gene mutants in yeast
• Metabolomic signatures of aggressive prostate cancer


Education & Training: 1997 Doctoral Thesis, Institute of Organic Chemistry, University of Tübingen, Germany
Employment & Experience: 2012 Venia Legendi for ”Medical Bioanalytics”, Faculty of Medicine, University of Freiburg, Germany
Since 2010 Head of Core Facility Metabolomics and Group Leader, Center for Biosystems Analysis ZBSA, Albert-Ludwigs-University Freiburg, Germany
2008 Habilitation at Institute of Medical Chemistry, University of Tübingen, Germany
Venia Legendi for “Pharmaceutical Analytics”, Faculty of Chemistry and Pharmacy, University of Tübingen, Germany
2001 - 2010 Laboratory Head and Group Leader at Institute of Pharmacology and Toxicology, Department of Clinical Pharmacology at University Hospital Tübingen, Germany
2000 – 2001 Laboratory Head Mass Spectrometry at University of Tübingen, Germany
1998 – 1999 Postdoctoral Position at Novartis Pharma AG, Basel, Switzerland
1997 – 1998 Scientific Assistant at Institute of Organic Chemistry, University of Tübingen, Germany


Selected Publications:

Willmann, Lucas; Erbes, Thalia; Halbach, Sebastian; Brummer, Tilman; Jaeger, Markus; Hirschfeld, Marc; Fehm, Tanja; Neubauer, Hans; Stickeler, Elmar; Kammerer, Bernd: “Exometabolom analysis of breast cancer cell lines: Metabolic signature”, Scientific Reports (2015), 5, 13374. Abstract

Willmann, Lucas; Erbes, Thalia; Krieger, Sonja; Trafkowski, Jens; Rodamer, Michael; Kammerer, Bernd: „Metabolome analysis via comprehensive two-dimensional liquid chromatography: identification of modified nucleosides from RNA metabolism”, Analytical and Bioanalytical Chemistry (2015), 407(13), 3555-3566. Abstract

Jaeger C, Tellström V,  Zurek G, König G, Eimer S, Kammerer B: “Metabolomic changes in Caenorhabditis elegans lifespan mutants as evident from GC–EI–MS and GC–APCI–TOF–MS profiling”, Metabolomics (2014), 10(5), 859-876. Abstract

Teperino R, Amann S, Bayer M, McGee SL, Loipetzberger A, Connor T, Jaeger C, Kammerer B, Winter L, Wiche G, Dalgaard K, Selvaraj M, Gaster M, Lee-Young RS, Febbraio MA, Knauf C, Cani PD, Aberger F, Penninger JM, Pospisilik JA, Esterbauer H: “Hedgehog Partial Agonism Drives Warburg-like Metabolism in Muscle and Brown Fat”, Cell 2012, 151(2):414-26. Abstract

Martin Michaelis, Florian Rothweiler, Denise Klassert, Andreas von Deimling, Kristoffer Weber, Boris Fehse, Bernd Kammerer, Hans Wilhelm Doerr, Jindrich Cinatl jr: “Reversal of P-glycoprotein-mediated multi-drug resistance by the MDM2 antagonist nutlin-3“, Cancer Research (2009), 69(2), 416-421. Abstract

Antje Frickenschmidt, Holger Fröhlich, Andreas Zell, Stefan Laufer, Christoph H. Gleiter, Hartmut Liebich and Bernd Kammerer: “Metabonomics in cancer diagnosis: Mass spectrometry based profiling of urinary nucleosides from breast cancer patients”, Biomarkers (2008), 13(4), 435-449. Abstract

Bernd Kammerer, Holger Scheible, Gabriela Zurek, Markus Godejohann, Klaus-Peter Zeller, Christoph H. Gleiter, Wolfgang Albrecht and Stefan Laufer: “In vitro metabolite identification of ML3403, a 4-pyridinylimidazole-type p38 MAP kinase inhibitor by LC-Qq-TOF-MS and LC-SPE-cryo-NMR/MS”, Xenobiotica (2007), 37(3), 280-297. Abstract

Dino Bullinger, Hans Neubauer, Tanja Fehm, Stefan Laufer, Christoph H. Gleiter and Bernd Kammerer: „Metabolic signature of breast cancer cell line MCF-7: Profiling of modified nucleosides via LC-IT MS coupling”, BMC Biochemistry (2007), 8(25) 1-14. Abstract

Kammerer, Bernd; Frickenschmidt, Antje; Laufer, Stefan; Gleiter, Christoph H. and Liebich, Hartmut: „MALDI-TOFMS Analysis of Urinary Nucleosides”, Journal of the American Society for Mass Spectrometry (2005), 16(6), 940-947. Abstract

Kammerer, Bernd; Kahlich, Rainer; Laufer, Stefan;  Li, Shuming; Heide, Lutz and Gleiter, Christoph H.: “Mass Spectrometric pathway monitoring of secondary metabolites - Systematic analysis of culture extracts of Streptomyces species”, Analytical Biochemistry (2004), 335, 17-29. Abstract

SGBM PhD students

SGBM PhD students:



Simon Lagies (April 2017-January 2021)

Manuel Schlimpert (October 2015-February 2019)

Copyright © 2009-2022 University of Freiburg